fda approves semaglutide weight-loss drug Wegovy to reduce heart-disease risks FDA approves obesity drug that

With prices often exceeding several hundred dollars per month, this can be a significant financial burden, particularly for those without insurance coverage

Achieving the right balance between GLP1R, GIPR and GR agonisation , would in principle be able to achieve even greater losses in weight, while still preserving lowering of blood glucose

The impact has been vast and further preclinical studies are still necessary to explore and understand the potential of the drugs that have already revolutionised the lives of millions of people with obesity and type 2 diabetes

Aim for at least 30 minutes of physical activity most days of the week to maximize weight loss and overall health

Given the chronic nature of RA and its associated comorbidities, there is a critical need to explore and establish effective management strategies to alleviate symptoms and improve patients quality of life